SLx-4090
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SLx-4090, covering 2021-08-19 to 2023-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides [Phase 2]